US$ 21.44
glp-1 agonist medications Study finds receptor agonists target fat over muscle for weight loss GLP-1 Medications for Weight Loss:
Description
Tang ASP, Hsu JTY, Chong SKS et al (2025) Glucagon-like peptide-1 receptor agonist in myocardial infarction and atherosclerotic cardiovascular disease risk reduction: a comprehensive meta-analysis of number needed to treat, efficacy and safety

The countrys aging population, high diabetes prevalence among older adults, and strong regulatory pathways for innovative therapies [3], influences growth

Based on application, the GLP-1 receptor agonist market is classified into obesity, type 2 diabetes mellitus, and other applications

Measurement of size and turnover rate of body glucose pool by the isotope dilution method

It supports strength, mobility, insulin sensitivity, posture, balance, healthy aging, and long-term weight maintenance

Several uncertainties remain
